Oramed Pharmaceuticals Inc (ORMP)
2.33
+0.02
(+0.87%)
USD |
NASDAQ |
Nov 22, 15:10
Oramed Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| November 30, 2021 | 0.00 |
| August 31, 2021 | 0.00 |
| May 31, 2021 | 0.00 |
| February 28, 2021 | 0.00 |
| November 30, 2020 | 0.00 |
| August 31, 2020 | 0.00 |
| May 31, 2020 | 0.00 |
| February 29, 2020 | 0.00 |
| November 30, 2019 | 0.00 |
| Date | Value |
|---|---|
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 0.00 |
| May 31, 2018 | 0.00 |
| February 28, 2018 | 0.00 |
| November 30, 2017 | 0.00 |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
| August 31, 2016 | 0.00 |
| May 31, 2016 | 0.00 |
| February 29, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Nov 2019
--
Maximum
Nov 2019
--
Average
--
Median
Nov 2019
Debt to Equity Ratio Benchmarks
| Skye Bioscience Inc | -- |
| Scilex Holding Co | -0.4863 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 165.08M |
| Total Liabilities (Quarterly) | 9.559M |
| Shareholders Equity (Quarterly) | 156.44M |